Zhitong Finance App News, Haizheng Pharmaceutical (600267.SH) issued an announcement. Recently, the product Glucosamine Hydrochloride from Zhejiang Yusheng Synthetic Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, completed the self-GRAs scientific evaluation and obtained unanimous approval from the expert group in accordance with the US FDA GRAS standards, and officially passed the US Self-GRAs certification.

According to reports, glucosamine hydrochloride is a high-value food-grade raw material and is widely used in food formulations and nutritional ingredients. In the US market, this product can be used as a food ingredient and used in various food categories such as specific foods and meal replacement foods under the intended use conditions. Passing Self-GRAS certification this time means that the product can be sold and used as a safe dietary ingredient in the US market and other international markets that have approved the US GRAS certification, further enriching the company's profit structure and laying a key foundation for the global layout of the company's dietary business.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.